Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2019) 65 P277 | DOI: 10.1530/endoabs.65.P277

SFEBES2019 POSTER PRESENTATIONS Neuroendocrinology (65 abstracts)

Secondary hormonal deficiency patterns vary among different types of sellar masses despite similar size at presentation

Stephanie M Kaiser 1, , Wael Almistehi 1 , Andrea Hebb 2 , David B Clarke 1, & Syed Ali Imran 1,


1Dalhousie University, Halifax, Canada; 2QEII Health Sciences Centre, Halifax, Canada


Secondary hormonal deficiency (SHD) in sellar masses (SM) is thought to be partly due to compression of the portal vessels by the enlarging tumour restricting the blood supply to the normal pituitary tissue. However, to date no study has looked at the patterns of SHD in various types of SM and assessed if SHD is related solely to the size of SM or is associated with the underlying pathology. We assessed 914 patients with SM enrolled in our comprehensive pituitary registry since November 2005 and analyzed the pattern of SHD at presentation in relation to tumour type and size at presentation. While there was an overall trend of a higher rate of SHD in larger SM (P<0.0001), the rates of SHD were significantly different in various types of SM despite similar size. The rates of SHD in SM < 9 mm were: Nonfunctioning adenoma [NFA] (10%), Prolactinoma (49%), GH adenoma (13%), ACTH adenoma (33%), craniophaygioma (50%), meningioma (0%) and Rathke’s cleft cyst [RCC] (11%); 10–19 mm were: NFA (35%), Prolactinoma (73%), ACTH adenoma (30%), GH adenoma (23%), craniopharyngioma (48%), meningioma (5%) and RCC (17%); 20–29 mm were: NFA (64%), Prolactinoma (78%), ACTH adenoma (100%), GH adenoma (75%), meningioma (16%), craniopharyngioma (70%) and RCC (41%) and > 30 mm were: NFA (83%), Prolactinoma (100%), GH adenoma (80%), meningioma (27%) and craniopharyngioma (88%) (all P <0.001). Furthermore, of the two largest categories of SM, NFA have higher odds ratio (3.34; CI = 1.89–5.89) of presenting with multiple SHD when compared to prolactinomas, despite similarity in gender, age and size of the tumour (P<0.001). These novel data suggest that SHD patterns vary among different types of SM and are not solely dependent on tumour size. Our data also show that NFA are more likely to present with multiple hormonal deficiencies.

Volume 65

Society for Endocrinology BES 2019

Brighton, United Kingdom
11 Nov 2019 - 13 Nov 2019

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.